Submitted by Anonymous (not verified) on 22 April 2026 - 15:40
Orphan designation: upadacitinib Treatment of systemic sclerosis, 20/04/2026 Positive
Source:
Orphan designation: upadacitinib Treatment of systemic sclerosis, 20/04/2026 Positive